시장조사 보고서 : 세계의 연쇄상 구균 폐렴 백신 시장예측 2021년-2026년

■ 영문 제목 : Global Streptococcus Pneumoniae Vaccine Market Growth 2021-2026
	■ 상품코드 : LPI-2108K201879 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 8월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 176 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (20명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 연쇄상 구균 폐렴 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (7 -가, 10 -가, 13 -가, 15 -가, 23 -가, 기타)와 용도별 시장규모 (2세 이하 어린이, 65세 이상 성인, 19세 이상 64세 이하 흡연자, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 연쇄상 구균 폐렴 백신 시장 점유율
- 지역별 연쇄상 구균 폐렴 백신 시장규모
- 주요지역의 종류별 시장규모 (7 -가, 10 -가, 13 -가, 15 -가, 23 -가, 기타)
- 주요지역의 용도별 시장규모 (2세 이하 어린이, 65세 이상 성인, 19세 이상 64세 이하 흡연자, 기타)
- 미주의 연쇄상 구균 폐렴 백신 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 연쇄상 구균 폐렴 백신 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 연쇄상 구균 폐렴 백신 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 연쇄상 구균 폐렴 백신 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 연쇄상 구균 폐렴 백신 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Streptococcus Pneumoniae Vaccine will have significant change from previous year. By the most conservative estimates of global Streptococcus Pneumoniae Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Streptococcus Pneumoniae Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Streptococcus Pneumoniae Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
7 -Valent
10 -Valent
13 -Valent
15 -Valent
23 -Valent
Other

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Children under 2 Years of Age
Adults over 65 Years of Age
Addicted Smokers Between the Ages of 19 and 64
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Pfizer
Sanofi
GSK
Merck
Eli Lilly
AstraZeneca
Abera
S K Chemicals
Beijing Minhai Biotechnology
Baxter
Biken
Celgene Corporation
Panacea Biotec
Serum Institute of India
Genentech
Genocea Biosciences
ImmunoBiology
Lupin
Nuron Biotech
Biogen
Valneva Austria
Sinovac

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Streptococcus Pneumoniae Vaccine Consumption 2016-2026
2.1.2 Streptococcus Pneumoniae Vaccine Consumption CAGR by Region
2.2 Streptococcus Pneumoniae Vaccine Segment by Type
2.2.1 7 -Valent
2.2.2 10 -Valent
2.2.3 13 -Valent
2.2.4 15 -Valent
2.2.5 23 -Valent
2.2.6 Other
2.3 Streptococcus Pneumoniae Vaccine Sales by Type
2.3.1 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2016-2021)
2.3.2 Global Streptococcus Pneumoniae Vaccine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Streptococcus Pneumoniae Vaccine Sale Price by Type (2016-2021)
2.4 Streptococcus Pneumoniae Vaccine Segment by Application
2.4.1 Children under 2 Years of Age
2.4.2 Adults over 65 Years of Age
2.4.3 Addicted Smokers Between the Ages of 19 and 64
2.4.4 Other
2.5 Streptococcus Pneumoniae Vaccine Sales by Application
2.5.1 Global Streptococcus Pneumoniae Vaccine Sale Market Share by Application (2016-2021)
2.5.2 Global Streptococcus Pneumoniae Vaccine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Streptococcus Pneumoniae Vaccine Sale Price by Application (2016-2021)

3 Global Streptococcus Pneumoniae Vaccine by Company
3.1 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Company
3.1.1 Global Streptococcus Pneumoniae Vaccine Sales by Company (2019-2021)
3.1.2 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Company (2019-2021)
3.2 Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Company
3.2.1 Global Streptococcus Pneumoniae Vaccine Revenue by Company (2019-2021)
3.2.2 Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Company (2019-2021)
3.3 Global Streptococcus Pneumoniae Vaccine Sale Price by Company
3.4 Global Manufacturers Streptococcus Pneumoniae Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Streptococcus Pneumoniae Vaccine Product Location Distribution
3.4.2 Players Streptococcus Pneumoniae Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Streptococcus Pneumoniae Vaccine by Region
4.1 Global Streptococcus Pneumoniae Vaccine by Region
4.1.1 Global Streptococcus Pneumoniae Vaccine Sales by Region
4.1.2 Global Streptococcus Pneumoniae Vaccine Revenue by Region
4.2 Americas Streptococcus Pneumoniae Vaccine Sales Growth
4.3 APAC Streptococcus Pneumoniae Vaccine Sales Growth
4.4 Europe Streptococcus Pneumoniae Vaccine Sales Growth
4.5 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Growth

5 Americas
5.1 Americas Streptococcus Pneumoniae Vaccine Sales by Country
5.1.1 Americas Streptococcus Pneumoniae Vaccine Sales by Country (2016-2021)
5.1.2 Americas Streptococcus Pneumoniae Vaccine Revenue by Country (2016-2021)
5.2 Americas Streptococcus Pneumoniae Vaccine Sales by Type
5.3 Americas Streptococcus Pneumoniae Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Streptococcus Pneumoniae Vaccine Sales by Region
6.1.1 APAC Streptococcus Pneumoniae Vaccine Sales by Region (2016-2021)
6.1.2 APAC Streptococcus Pneumoniae Vaccine Revenue by Region (2016-2021)
6.2 APAC Streptococcus Pneumoniae Vaccine Sales by Type
6.3 APAC Streptococcus Pneumoniae Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Streptococcus Pneumoniae Vaccine by Country
7.1.1 Europe Streptococcus Pneumoniae Vaccine Sales by Country (2016-2021)
7.1.2 Europe Streptococcus Pneumoniae Vaccine Revenue by Country (2016-2021)
7.2 Europe Streptococcus Pneumoniae Vaccine Sales by Type
7.3 Europe Streptococcus Pneumoniae Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Streptococcus Pneumoniae Vaccine by Country
8.1.1 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue by Country (2016-2021)
8.2 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Type
8.3 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Streptococcus Pneumoniae Vaccine Distributors
10.3 Streptococcus Pneumoniae Vaccine Customer

11 Global Streptococcus Pneumoniae Vaccine Market Forecast
11.1 Global Streptococcus Pneumoniae Vaccine Forecast by Region
11.1.1 Global Streptococcus Pneumoniae Vaccine Forecast by Regions (2021-2026)
11.2.2 Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Streptococcus Pneumoniae Vaccine Forecast by Type
11.7 Global Streptococcus Pneumoniae Vaccine Forecast by Application

12 Key Players Analysis
12.1 Pfizer
12.1.1 Pfizer Company Information
12.1.2 Pfizer Streptococcus Pneumoniae Vaccine Product Offered
12.1.3 Pfizer Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Pfizer Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 Sanofi
12.2.1 Sanofi Company Information
12.2.2 Sanofi Streptococcus Pneumoniae Vaccine Product Offered
12.2.3 Sanofi Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Sanofi Main Business Overview
12.2.5 Sanofi Latest Developments
12.3 GSK
12.3.1 GSK Company Information
12.3.2 GSK Streptococcus Pneumoniae Vaccine Product Offered
12.3.3 GSK Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 GSK Main Business Overview
12.3.5 GSK Latest Developments
12.4 Merck
12.4.1 Merck Company Information
12.4.2 Merck Streptococcus Pneumoniae Vaccine Product Offered
12.4.3 Merck Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Merck Main Business Overview
12.4.5 Merck Latest Developments
12.5 Eli Lilly
12.5.1 Eli Lilly Company Information
12.5.2 Eli Lilly Streptococcus Pneumoniae Vaccine Product Offered
12.5.3 Eli Lilly Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Eli Lilly Main Business Overview
12.5.5 Eli Lilly Latest Developments
12.6 AstraZeneca
12.6.1 AstraZeneca Company Information
12.6.2 AstraZeneca Streptococcus Pneumoniae Vaccine Product Offered
12.6.3 AstraZeneca Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 AstraZeneca Main Business Overview
12.6.5 AstraZeneca Latest Developments
12.7 Abera
12.7.1 Abera Company Information
12.7.2 Abera Streptococcus Pneumoniae Vaccine Product Offered
12.7.3 Abera Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Abera Main Business Overview
12.7.5 Abera Latest Developments
12.8 S K Chemicals
12.8.1 S K Chemicals Company Information
12.8.2 S K Chemicals Streptococcus Pneumoniae Vaccine Product Offered
12.8.3 S K Chemicals Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 S K Chemicals Main Business Overview
12.8.5 S K Chemicals Latest Developments
12.9 Beijing Minhai Biotechnology
12.9.1 Beijing Minhai Biotechnology Company Information
12.9.2 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Product Offered
12.9.3 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Beijing Minhai Biotechnology Main Business Overview
12.9.5 Beijing Minhai Biotechnology Latest Developments
12.10 Baxter
12.10.1 Baxter Company Information
12.10.2 Baxter Streptococcus Pneumoniae Vaccine Product Offered
12.10.3 Baxter Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Baxter Main Business Overview
12.10.5 Baxter Latest Developments
12.11 Biken
12.11.1 Biken Company Information
12.11.2 Biken Streptococcus Pneumoniae Vaccine Product Offered
12.11.3 Biken Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Biken Main Business Overview
12.11.5 Biken Latest Developments
12.12 Celgene Corporation
12.12.1 Celgene Corporation Company Information
12.12.2 Celgene Corporation Streptococcus Pneumoniae Vaccine Product Offered
12.12.3 Celgene Corporation Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Celgene Corporation Main Business Overview
12.12.5 Celgene Corporation Latest Developments
12.13 Panacea Biotec
12.13.1 Panacea Biotec Company Information
12.13.2 Panacea Biotec Streptococcus Pneumoniae Vaccine Product Offered
12.13.3 Panacea Biotec Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Panacea Biotec Main Business Overview
12.13.5 Panacea Biotec Latest Developments
12.14 Serum Institute of India
12.14.1 Serum Institute of India Company Information
12.14.2 Serum Institute of India Streptococcus Pneumoniae Vaccine Product Offered
12.14.3 Serum Institute of India Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Serum Institute of India Main Business Overview
12.14.5 Serum Institute of India Latest Developments
12.15 Genentech
12.15.1 Genentech Company Information
12.15.2 Genentech Streptococcus Pneumoniae Vaccine Product Offered
12.15.3 Genentech Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Genentech Main Business Overview
12.15.5 Genentech Latest Developments
12.16 Genocea Biosciences
12.16.1 Genocea Biosciences Company Information
12.16.2 Genocea Biosciences Streptococcus Pneumoniae Vaccine Product Offered
12.16.3 Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Genocea Biosciences Main Business Overview
12.16.5 Genocea Biosciences Latest Developments
12.17 ImmunoBiology
12.17.1 ImmunoBiology Company Information
12.17.2 ImmunoBiology Streptococcus Pneumoniae Vaccine Product Offered
12.17.3 ImmunoBiology Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 ImmunoBiology Main Business Overview
12.17.5 ImmunoBiology Latest Developments
12.18 Lupin
12.18.1 Lupin Company Information
12.18.2 Lupin Streptococcus Pneumoniae Vaccine Product Offered
12.18.3 Lupin Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 Lupin Main Business Overview
12.18.5 Lupin Latest Developments
12.19 Nuron Biotech
12.19.1 Nuron Biotech Company Information
12.19.2 Nuron Biotech Streptococcus Pneumoniae Vaccine Product Offered
12.19.3 Nuron Biotech Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 Nuron Biotech Main Business Overview
12.19.5 Nuron Biotech Latest Developments
12.20 Biogen
12.20.1 Biogen Company Information
12.20.2 Biogen Streptococcus Pneumoniae Vaccine Product Offered
12.20.3 Biogen Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.20.4 Biogen Main Business Overview
12.20.5 Biogen Latest Developments
12.21 Valneva Austria
12.21.1 Valneva Austria Company Information
12.21.2 Valneva Austria Streptococcus Pneumoniae Vaccine Product Offered
12.21.3 Valneva Austria Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.21.4 Valneva Austria Main Business Overview
12.21.5 Valneva Austria Latest Developments
12.22 Sinovac
12.22.1 Sinovac Company Information
12.22.2 Sinovac Streptococcus Pneumoniae Vaccine Product Offered
12.22.3 Sinovac Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.22.4 Sinovac Main Business Overview
12.22.5 Sinovac Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Streptococcus Pneumoniae Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of 7 -Valent
Table 3. Major Players of 10 -Valent
Table 4. Major Players of 13 -Valent
Table 5. Major Players of 15 -Valent
Table 6. Major Players of 23 -Valent
Table 7. Major Players of Other
Table 8. Global Streptococcus Pneumoniae Vaccine Sales by Type (2016-2021) & (K Units)
Table 9. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2016-2021)
Table 10. Global Streptococcus Pneumoniae Vaccine Revenue by Type (2016-2021) & ($ million)
Table 11. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Type (2016-2021)
Table 12. Global Streptococcus Pneumoniae Vaccine Sale Price by Type (2016-2021)
Table 13. Global Streptococcus Pneumoniae Vaccine Sales by Application (2016-2021) & (K Units)
Table 14. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2016-2021)
Table 15. Global Streptococcus Pneumoniae Vaccine Value by Application (2016-2021)
Table 16. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Application (2016-2021)
Table 17. Global Streptococcus Pneumoniae Vaccine Sale Price by Application (2016-2021)
Table 18. Global Streptococcus Pneumoniae Vaccine Sales by Company (2019-2021) & (K Units)
Table 19. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Company (2019-2021)
Table 20. Global Streptococcus Pneumoniae Vaccine Revenue by Company (2019-2021) ($ Millions)
Table 21. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Company (2019-2021)
Table 22. Global Streptococcus Pneumoniae Vaccine Sale Price by Company (2019-2021)
Table 23. Key Manufacturers Streptococcus Pneumoniae Vaccine Producing Area Distribution and Sales Area
Table 24. Players Streptococcus Pneumoniae Vaccine Products Offered
Table 25. Streptococcus Pneumoniae Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Streptococcus Pneumoniae Vaccine Sales by Region (2016-2021) (K Units)
Table 29. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Region (2016-2021)
Table 30. Global Streptococcus Pneumoniae Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 31. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Region (2016-2021)
Table 32. Americas Streptococcus Pneumoniae Vaccine Sales by Country (2016-2021) & (K Units)
Table 33. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2016-2021)
Table 34. Americas Streptococcus Pneumoniae Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 35. Americas Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2016-2021)
Table 36. Americas Streptococcus Pneumoniae Vaccine Sales by Type (2016-2021) & (K Units)
Table 37. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2016-2021)
Table 38. Americas Streptococcus Pneumoniae Vaccine Sales by Application (2016-2021) & (K Units)
Table 39. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2016-2021)
Table 40. APAC Streptococcus Pneumoniae Vaccine Sales by Region (2016-2021) & (K Units)
Table 41. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Region (2016-2021)
Table 42. APAC Streptococcus Pneumoniae Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 43. APAC Streptococcus Pneumoniae Vaccine Revenue Market Share by Region (2016-2021)
Table 44. APAC Streptococcus Pneumoniae Vaccine Sales by Type (2016-2021) & (K Units)
Table 45. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2016-2021)
Table 46. APAC Streptococcus Pneumoniae Vaccine Sales by Application (2016-2021) & (K Units)
Table 47. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2016-2021)
Table 48. Europe Streptococcus Pneumoniae Vaccine Sales by Country (2016-2021) & (K Units)
Table 49. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2016-2021)
Table 50. Europe Streptococcus Pneumoniae Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 51. Europe Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2016-2021)
Table 52. Europe Streptococcus Pneumoniae Vaccine Sales by Type (2016-2021) & (K Units)
Table 53. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2016-2021)
Table 54. Europe Streptococcus Pneumoniae Vaccine Sales by Application (2016-2021) & (K Units)
Table 55. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2016-2021)
Table 56. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Country (2016-2021) & (K Units)
Table 57. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2016-2021)
Table 58. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 59. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2016-2021)
Table 60. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Type (2016-2021) & (K Units)
Table 61. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2016-2021)
Table 62. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Application (2016-2021) & (K Units)
Table 63. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2016-2021)
Table 64. Key and Potential Regions of Streptococcus Pneumoniae Vaccine
Table 65. Key Application and Potential Industries of Streptococcus Pneumoniae Vaccine
Table 66. Key Challenges of Streptococcus Pneumoniae Vaccine
Table 67. Key Trends of Streptococcus Pneumoniae Vaccine
Table 68. Streptococcus Pneumoniae Vaccine Distributors List
Table 69. Streptococcus Pneumoniae Vaccine Customer List
Table 70. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Region (2021-2026) & (K Units)
Table 71. Global Streptococcus Pneumoniae Vaccine Consumption Market Forecast by Region
Table 72. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 73. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 74. Americas Streptococcus Pneumoniae Vaccine Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Americas Streptococcus Pneumoniae Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. APAC Streptococcus Pneumoniae Vaccine Sales Forecast by Region (2021-2026) & (K Units)
Table 77. APAC Streptococcus Pneumoniae Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 78. Europe Streptococcus Pneumoniae Vaccine Sales Forecast by Country (2021-2026) & (K Units)
Table 79. Europe Streptococcus Pneumoniae Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Forecast by Country (2021-2026) & (K Units)
Table 81. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 82. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Type (2021-2026) & (K Units)
Table 83. Global Streptococcus Pneumoniae Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 84. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 85. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Type (2021-2026)
Table 86. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Application (2021-2026) & (K Units)
Table 87. Global Streptococcus Pneumoniae Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 88. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 89. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 90. Pfizer Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 91. Pfizer Streptococcus Pneumoniae Vaccine Product Offered
Table 92. Pfizer Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 93. Pfizer Main Business
Table 94. Pfizer Latest Developments
Table 95. Sanofi Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. Sanofi Streptococcus Pneumoniae Vaccine Product Offered
Table 97. Sanofi Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 98. Sanofi Main Business
Table 99. Sanofi Latest Developments
Table 100. GSK Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. GSK Streptococcus Pneumoniae Vaccine Product Offered
Table 102. GSK Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 103. GSK Main Business
Table 104. GSK Latest Developments
Table 105. Merck Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. Merck Streptococcus Pneumoniae Vaccine Product Offered
Table 107. Merck Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 108. Merck Main Business
Table 109. Merck Latest Developments
Table 110. Eli Lilly Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 111. Eli Lilly Streptococcus Pneumoniae Vaccine Product Offered
Table 112. Eli Lilly Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 113. Eli Lilly Main Business
Table 114. Eli Lilly Latest Developments
Table 115. AstraZeneca Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 116. AstraZeneca Streptococcus Pneumoniae Vaccine Product Offered
Table 117. AstraZeneca Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 118. AstraZeneca Main Business
Table 119. AstraZeneca Latest Developments
Table 120. Abera Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 121. Abera Streptococcus Pneumoniae Vaccine Product Offered
Table 122. Abera Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 123. Abera Main Business
Table 124. Abera Latest Developments
Table 125. S K Chemicals Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 126. S K Chemicals Streptococcus Pneumoniae Vaccine Product Offered
Table 127. S K Chemicals Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 128. S K Chemicals Main Business
Table 129. S K Chemicals Latest Developments
Table 130. Beijing Minhai Biotechnology Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 131. Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Product Offered
Table 132. Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 133. Beijing Minhai Biotechnology Main Business
Table 134. Beijing Minhai Biotechnology Latest Developments
Table 135. Baxter Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 136. Baxter Streptococcus Pneumoniae Vaccine Product Offered
Table 137. Baxter Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 138. Baxter Main Business
Table 139. Baxter Latest Developments
Table 140. Biken Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 141. Biken Streptococcus Pneumoniae Vaccine Product Offered
Table 142. Biken Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 143. Biken Main Business
Table 144. Biken Latest Developments
Table 145. Celgene Corporation Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 146. Celgene Corporation Streptococcus Pneumoniae Vaccine Product Offered
Table 147. Celgene Corporation Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 148. Celgene Corporation Main Business
Table 149. Celgene Corporation Latest Developments
Table 150. Panacea Biotec Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 151. Panacea Biotec Streptococcus Pneumoniae Vaccine Product Offered
Table 152. Panacea Biotec Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 153. Panacea Biotec Main Business
Table 154. Panacea Biotec Latest Developments
Table 155. Serum Institute of India Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 156. Serum Institute of India Streptococcus Pneumoniae Vaccine Product Offered
Table 157. Serum Institute of India Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 158. Serum Institute of India Main Business
Table 159. Serum Institute of India Latest Developments
Table 160. Genentech Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 161. Genentech Streptococcus Pneumoniae Vaccine Product Offered
Table 162. Genentech Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 163. Genentech Main Business
Table 164. Genentech Latest Developments
Table 165. Genocea Biosciences Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 166. Genocea Biosciences Streptococcus Pneumoniae Vaccine Product Offered
Table 167. Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 168. Genocea Biosciences Main Business
Table 169. Genocea Biosciences Latest Developments
Table 170. ImmunoBiology Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 171. ImmunoBiology Streptococcus Pneumoniae Vaccine Product Offered
Table 172. ImmunoBiology Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 173. ImmunoBiology Main Business
Table 174. ImmunoBiology Latest Developments
Table 175. Lupin Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 176. Lupin Streptococcus Pneumoniae Vaccine Product Offered
Table 177. Lupin Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 178. Lupin Main Business
Table 179. Lupin Latest Developments
Table 180. Nuron Biotech Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 181. Nuron Biotech Streptococcus Pneumoniae Vaccine Product Offered
Table 182. Nuron Biotech Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 183. Nuron Biotech Main Business
Table 184. Nuron Biotech Latest Developments
Table 185. Biogen Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 186. Biogen Streptococcus Pneumoniae Vaccine Product Offered
Table 187. Biogen Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 188. Biogen Main Business
Table 189. Biogen Latest Developments
Table 190. Valneva Austria Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 191. Valneva Austria Streptococcus Pneumoniae Vaccine Product Offered
Table 192. Valneva Austria Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 193. Valneva Austria Main Business
Table 194. Valneva Austria Latest Developments
Table 195. Sinovac Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 196. Sinovac Streptococcus Pneumoniae Vaccine Product Offered
Table 197. Sinovac Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 198. Sinovac Main Business
Table 199. Sinovac Latest Developments
List of Figures
Figure 1. Picture of Streptococcus Pneumoniae Vaccine
Figure 2. Streptococcus Pneumoniae Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Streptococcus Pneumoniae Vaccine Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Streptococcus Pneumoniae Vaccine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Streptococcus Pneumoniae Vaccine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of 7 -Valent
Figure 10. Product Picture of 10 -Valent
Figure 11. Product Picture of 13 -Valent
Figure 12. Product Picture of 15 -Valent
Figure 13. Product Picture of 23 -Valent
Figure 14. Product Picture of Other
Figure 15. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type in 2020
Figure 16. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Type (2016-2021)
Figure 17. Streptococcus Pneumoniae Vaccine Consumed in Children under 2 Years of Age
Figure 18. Global Streptococcus Pneumoniae Vaccine Market: Children under 2 Years of Age (2016-2021) & (K Units)
Figure 19. Streptococcus Pneumoniae Vaccine Consumed in Adults over 65 Years of Age
Figure 20. Global Streptococcus Pneumoniae Vaccine Market: Adults over 65 Years of Age (2016-2021) & (K Units)
Figure 21. Streptococcus Pneumoniae Vaccine Consumed in Addicted Smokers Between the Ages of 19 and 64
Figure 22. Global Streptococcus Pneumoniae Vaccine Market: Addicted Smokers Between the Ages of 19 and 64 (2016-2021) & (K Units)
Figure 23. Streptococcus Pneumoniae Vaccine Consumed in Other
Figure 24. Global Streptococcus Pneumoniae Vaccine Market: Other (2016-2021) & (K Units)
Figure 25. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2016-2021)
Figure 26. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Application in 2020
Figure 27. Streptococcus Pneumoniae Vaccine Revenue Market by Company in 2020 ($ Million)
Figure 28. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Company in 2020
Figure 29. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Regions (2016-2021)
Figure 30. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Region in 2020
Figure 31. Americas Streptococcus Pneumoniae Vaccine Sales 2016-2021 (K Units)
Figure 32. Americas Streptococcus Pneumoniae Vaccine Revenue 2016-2021 ($ Millions)
Figure 33. APAC Streptococcus Pneumoniae Vaccine Sales 2016-2021 (K Units)
Figure 34. APAC Streptococcus Pneumoniae Vaccine Revenue 2016-2021 ($ Millions)
Figure 35. Europe Streptococcus Pneumoniae Vaccine Sales 2016-2021 (K Units)
Figure 36. Europe Streptococcus Pneumoniae Vaccine Revenue 2016-2021 ($ Millions)
Figure 37. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales 2016-2021 (K Units)
Figure 38. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue 2016-2021 ($ Millions)
Figure 39. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Country in 2020
Figure 40. Americas Streptococcus Pneumoniae Vaccine Revenue Market Share by Country in 2020
Figure 41. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Type in 2020
Figure 42. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Application in 2020
Figure 43. United States Streptococcus Pneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 44. Canada Streptococcus Pneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 45. Mexico Streptococcus Pneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 46. Brazil Streptococcus Pneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 47. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Region in 2020
Figure 48. APAC Streptococcus Pneumoniae Vaccine Revenue Market Share by Regions in 2020
Figure 49. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Type in 2020
Figure 50. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Application in 2020
Figure 51. China Streptococcus Pneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 52. Japan Streptococcus Pneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 53. Korea Streptococcus Pneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 54. Southeast Asia Streptococcus Pneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 55. India Streptococcus Pneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 56. Australia Streptococcus Pneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 57. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Country in 2020
Figure 58. Europe Streptococcus Pneumoniae Vaccine Revenue Market Share by Country in 2020
Figure 59. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Type in 2020
Figure 60. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Application in 2020
Figure 61. Germany Streptococcus Pneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 62. France Streptococcus Pneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 63. UK Streptococcus Pneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 64. Italy Streptococcus Pneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 65. Russia Streptococcus Pneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 66. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Country in 2020
Figure 67. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue Market Share by Country in 2020
Figure 68. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Type in 2020
Figure 69. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Application in 2020
Figure 70. Egypt Streptococcus Pneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 71. South Africa Streptococcus Pneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 72. Israel Streptococcus Pneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 73. Turkey Streptococcus Pneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 74. GCC Country Streptococcus Pneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles

※본 조사보고서 [세계의 연쇄상 구균 폐렴 백신 시장예측 2021년-2026년] (코드 : LPI-2108K201879) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 연쇄상 구균 폐렴 백신 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 BCG 백신 판매 시장예측 2021년-2026년
LPI-2108K202111 / LP Information / 2021년 8월 / 본 조사보고서는 BCG 백신 판매의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of BCG Vaccine Sales will have significant change from previous year. By the most conservative estimates of global BCG Vaccine Sales market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 23가 폐렴구균 백신 시장예측 2021년-2026년
LPI-2108K202091 / LP Information / 2021년 8월 / 본 조사보고서는 23가 폐렴구균 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of 23-valent Pneumococcal Vaccine will have significant change from previous year. By the most conservative estimates of global 23-valent Pneumococcal Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 브루셀라 아보투스 백신 시장예측 2021년-2026년
LPI-2108K202124 / LP Information / 2021년 8월 / 본 조사보고서는 브루셀라 아보투스 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Brucella Abortus Vaccine will have significant change from previous year. By the most conservative estimates of global Brucella Abortus Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 태양 전지식 백신 냉장고 시장예측 2021년-2026년
LPI-2108K201854 / LP Information / 2021년 8월 / 본 조사보고서는 태양 전지식 백신 냉장고의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Solar-powered Vaccine Refrigerators will have significant change from previous year. By the most conservative estimates of global Solar-powered Vaccine Refrigerators market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 상업수산용 백신 시장예측 2021년-2026년
LPI-2108K200015 / LP Information / 2021년 8월 / 본 조사보고서는 상업수산용 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Commercial Aquaculture Vaccines will have significant change from previous year. By the most conservative estimates of global Commercial Aquaculture Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 아미노산 배양 배지 시장예측 2021년-2026년
LPI-2108K202137 / LP Information / 2021년 8월 / 본 조사보고서는 아미노산 배양 배지의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Amino Acid Culture Media will have significant change from previous year. By the most conservative estimates of global Amino Acid Culture Media market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2950.4...

세계의 기존형 CTG 시장예측 2021년-2026년
LPI-2108K201922 / LP Information / 2021년 8월 / 본 조사보고서는 기존형 CTG의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Traditional CTG will have significant change from previous year. By the most conservative estimates of global Traditional CTG market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over...

세계의 가정용 응급 처치 키트 시장예측 2021년-2026년
LPI-2108K200069 / LP Information / 2021년 8월 / 본 조사보고서는 가정용 응급 처치 키트의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Residential First Aid Kit will have significant change from previous year. By the most conservative estimates of global Residential First Aid Kit market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 당뇨병 치료약 시장예측 2021년-2026년
LPI-2108K202104 / LP Information / 2021년 8월 / 본 조사보고서는 당뇨병 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Antidiabetic Drugs will have significant change from previous year. By the most conservative estimates of global Antidiabetic Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over...

세계의 MRI 스캐너 시장예측 2021년-2026년
LPI-2108K201614 / LP Information / 2021년 8월 / 본 조사보고서는 MRI 스캐너의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of MRI Scanner will have significant change from previous year. By the most conservative estimates of global MRI Scanner market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over...